⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

James TaylorM.D.

Hematology-Oncology · Washington, DC 20060

NPI: 1487689295

Share:𝕏fin

30

🟠 Elevated

Risk Flags

Very high opioid rate vs specialty peers90th percentile opioid prescribingElevated cost per beneficiaryElevated long-acting opioid rate

Risk indicators are statistical patterns, not allegations. Learn more

454

Total Claims

$534K

Drug Cost

29

Beneficiaries

$18K

Cost/Patient

Risk Score Breakdown 30/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+18
Opioid rate (national percentile)+5
Long-acting opioid rate+4
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 8,541 Hematology-Oncology providers

+546%

Opioid rate vs peers

40.5% vs 6.3% avg

+35%

Cost per patient vs peers

$18K vs $14K avg

+15%

Brand preference vs peers

16.7% vs 14.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

40.5%

Opioid Rate

184

Opioid Claims

$13K

Opioid Cost

37.0%

Long-Acting Rate

This provider's opioid prescribing rate of 40.5% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

83% generic

Brand: 76 claims · $495K

Generic: 378 claims · $39K

Patient Profile

46

Avg Age

48%

Female

4.98

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About